miR-205 is involved in metastatic potential of 21T series, a breast cancer progression model
© Stankevicins et al; licensee BioMed Central Ltd. 2013
Published: 4 April 2013
microRNA (miRNA) is a class of non-coding RNAs, which regulate gene expression at the post-transcriptional level. Many miRNAs have been implicated in several human cancers, as these regulatory molecules play important roles in key cellular processes, including cell proliferation, differentiation and response to DNA damage.
To gain insights into the mechanisms involved in breast cancer initiation and progression we conducted a miRNA global expression on 21T series. These cell lines represent an in vitro model of breast cancer progression comprising immortalized cell lines derived from the same patient diagnosed with Her-2 overexpressing ductal carcinoma. The set include a normal epithelia (16N), primary in situ ductal carcinoma (21PT and 21NT) and cells derived from pleural effusion of lung metastasis (21MT-1 and 21MT-2). To confirm microarray results, the expression of the most significantly altered miRNAs were checked by qPCR. Matrigel invasion assay was done to evaluate the migration capacity of 21Tcells and Her-2, ZEB-1 and e-cadherin protein levels were achieved by western blot.
Analysis of 21T series revealed a significant downregulation of miR-205 together with an enrichment of its predicted target, the pro-metastatic factor ZEB-1 and the consequent reduction of e-cadherin levels in the invasive 21MT cells.
These molecular alterations, in special the downregulation of miR-205 in cancer cells, can participate on modulation of epithelial to mesenchymal transition and increase the metastatic potential on breast cancer.
Faperj, CAPES, CNPq and Université Paris XI.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.